DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
Currently, a greater emphasis is placed on the search for additional biomarkers of chronic heart failure (CHF). Galectin-3, a marker of fibrosis and inflammation, has shown himself as a biomarker of CHF in many studies, but the dynamics of its levels in patients with concomitant diabetes mellitus (D...
Saved in:
Main Authors: | A. A. Snetkova (Author), N. Yu. Timofeeva (Author), V. S. Zadionchenko (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
by: A. A. Snetkova, et al.
Published: (2015) -
GALECTIN-3 AND MATRIX METALLOPROTEINASE-1 IN THE PATOGENESIS OF MYOCARDIAL DYSSYNCHRONY IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
by: T.A. Rudenko
Published: (2016) -
Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2022) -
Interrelation of galectin-3 and circulating proangiogenic endothelial cells in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014) -
Value of Galectin-3 assay in children with heart failure secondary to congenital heart diseases: a prospective study
by: Nagwan Saleh, et al.
Published: (2020)